Genvor Inc. Partners with B2i Digital to Showcase AI-Accelerated Agricultural Technology to Investors
TL;DR
Genvor's AI-accelerated peptide platform offers agricultural companies a competitive edge by reducing crop losses through sustainable biological solutions that outperform traditional methods.
Genvor's BioCypher Algorithm leverages 50,000 designed peptides and 30 years of research to systematically develop targeted solutions that reduce aflatoxin contamination by 76-98% in crops.
Genvor's sustainable agricultural solutions help create a better tomorrow by reducing global crop losses and providing safer, biological alternatives to chemical pesticides for food production.
Genvor's AI platform designs peptides that can reduce fungal toxins in corn by up to 98%, using computational biology to revolutionize crop protection.
Found this article helpful?
Share it with your network and spread the knowledge!

Genvor Inc. has joined the B2i Digital platform as a Featured Company to expand investor awareness of its AI-accelerated peptide platform and sustainable agricultural solutions. The partnership will showcase Genvor's technology through B2i Digital's multi-channel digital marketing engine and targeted outreach campaigns to investors interested in sustainable agriculture innovations. Genvor is developing sustainable crop-protection solutions through its proprietary BioCypher Algorithm, which targets the estimated $220 billion in annual global crop losses caused by plant pathogens. David Shapiro, CEO of B2i Digital, stated that he has been particularly impressed with Genvor's leadership and their ability to clearly articulate the growing demand for biological solutions in agriculture.
Genvor's BioCypher Algorithm leverages more than 50,000 designed peptides and over 30 years of foundational research to produce targeted solutions for major agricultural challenges. The platform has demonstrated broad-spectrum efficacy, including 76%–98% reductions in total aflatoxin contamination in transgenic corn seeds across pathogens such as Aspergillus flavus and Fusarium species. This technology represents a significant advancement in addressing persistent agricultural challenges through biological means rather than traditional chemical approaches. Chad Pawlak, CEO of Genvor, emphasized that this partnership comes at a key moment as the company experiences accelerated momentum with recently issued patents, active partnership discussions, and a growing pipeline.
The company maintains a growing intellectual property portfolio, including two issued U.S. patents and one pending application covering 24 proprietary peptides. In November 2025, Genvor announced the issuance of U.S. Patent No. 12,458,684 for transgenic corn expressing antifungal peptide AGM182, co-assigned to Genvor Inc. and the United States Department of Agriculture, representing a significant milestone in validating the commercial potential of Genvor's seed-trait technologies. Genvor's development pipeline spans multiple crops including corn, citrus, rice, soybeans, cotton, flax, and potato, with applications across both foliar spray solutions and seed traits.
The company is currently engaged with major agricultural companies on joint venture evaluations and commercialization discussions, positioning its technology for broad adoption across the agricultural sector. For more information about the company's technology and development progress, visit https://www.genvor.com. B2i Digital, founded in 2021 by former Maxim Group Investment Banker and Chief Marketing Officer David Shapiro, partners with leading investor conferences, public companies, and capital-markets advisors through its Featured Conference, Featured Company, and Featured Expert programs. The firm's proprietary network of more than 1.4 million market participants and its experience in supporting investor conferences make it a strategic partner for companies seeking institutional-quality exposure. Additional information about B2i Digital's platform and services can be found at https://b2idigital.com.
Curated from NewMediaWire
